Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsETFsIndustrySplitsCorrelations
Market CapEPSP/EP/SP/BSharesProfit MarginOperating MarginDebt to EquityRevenueEarningsEBITDAFree Cash FlowTotal DebtTotal AssetsROAROE

Leap Therapeutics (LPTX) Profit Margin (2020 - 2024)

Leap Therapeutics (LPTX) profit margin from Mar 31, 2020 to Dec 31, 2024. The current Leap Therapeutics (LPTX) profit margin is -154300.00%. You can export chart.

Annual Profit Margin

Quarterly Profit Margin

Annual Profit Margin change of Leap Therapeutics (LPTX)

YearProfit MarginChange
2022-14368.42%
+430.98%
2021-2706.00%
+47.55%
2020-1834.00%
-78.82%
2019-8657.89%
N/A

Comparison Leap Therapeutics (LPTX) profit margin with competitors

Leap Therapeutics (LPTX) profit margin is -154300.00%.

TickerNameProfit MarginUpside
OMEROmeros Corporation871.00%-100.56%
PRTCPureTech Health plc American Depositary Shares793.00%-100.51%
ABEOAbeona Therapeutics Inc454.90%-100.29%
CHRSCoherus Biosciences Inc397.30%-100.26%
FBIOFortress Biotech Inc193.10%-100.13%
INVAInnoviva Inc119.90%-100.08%
ZVRAZevra Therapeutics Inc101.60%-100.07%
ABUSArbutus Biopharma Corp94.73%-100.06%
SAVACassava Sciences Inc.93.68%-100.06%
GLPGGalapagos NV86.83%-100.06%
CTNMContineum Therapeutics Inc - Class A83.13%-100.05%
BDTXBlack Diamond Therapeutics Inc80.77%-100.05%
NEUPNeuphoria Therapeutics Inc75.08%-100.05%
IPSCCentury Therapeutics Inc70.13%-100.05%
FULCFulcrum Therapeutics Inc69.26%-100.04%
CVACCureVac N.V.68.44%-100.04%
PRTAProthena Corporation plc64.05%-100.04%
QTTBQ32 Bio Inc61.90%-100.04%
AVIRAtea Pharmaceuticals Inc60.95%-100.04%
ASNDAscendis Pharma A/S57.30%-100.04%
PLXProtalix BioTherapeutics Inc54.27%-100.04%
HCWBHCW Biologics Inc53.42%-100.03%
AGENAgenus Inc52.20%-100.03%
CGENCompugen Ltd48.57%-100.03%
KRYSKrystal Biotech Inc48.07%-100.03%
RPRXRoyalty Pharma plc - Class A46.73%-100.03%
XOMAPXOMA Royalty Corp45.90%-100.03%
XOMAOXOMA Royalty Corp45.90%-100.03%
AUPHAurinia Pharmaceuticals Inc44.21%-100.03%
NXTCNextcure Inc43.49%-100.03%
CPRXCatalyst Pharmaceuticals Inc42.66%-100.03%
HALOHalozyme Therapeutics Inc39.83%-100.03%
ADMAAdma Biologics Inc39.59%-100.03%
XOMAXOMA Royalty Corp36.25%-100.02%
VRTXVertex Pharmaceuticals Inc34.53%-100.02%
EXELExelixis Inc34.46%-100.02%
SLNOSoleno Therapeutics Inc33.17%-100.02%
CRMDCorMedix Inc30.29%-100.02%
TNGXTango Therapeutics Inc29.52%-100.02%
ARGXArgen X SE28.20%-100.02%
CAICaris Life Sciences Inc - Class A27.98%-100.02%
JAZZJazz Pharmaceuticals plc27.42%-100.02%
SPROSpero Therapeutics Inc24.90%-100.02%
INCYIncyte Corp23.83%-100.02%
REGNRegeneron Pharmaceuticals Inc20.17%-100.01%
NAGENiagen Bioscience Inc20.07%-100.01%
ICCCImmucell Corp18.75%-100.01%
NERVMinerva Neurosciences Inc17.79%-100.01%
ALNYAlnylam Pharmaceuticals Inc16.99%-100.01%
ENVBEnveric Biosciences Inc16.64%-100.01%
TECHBio-Techne Corp16.39%-100.01%
HRMYHarmony Biosciences Holdings Inc15.08%-100.01%
ONCBeiGene Ltd15.02%-100.01%
RIGLRigel Pharmaceuticals14.71%-100.01%
BMRNBiomarin Pharmaceutical Inc13.77%-100.01%
VXRTVaxart Inc13.20%-100.01%
IMCRImmunocore Holdings plc12.16%-100.01%
VRNAVerona Pharma Plc11.56%-100.01%
TGTXTG Therapeutics Inc9.65%-100.01%
APLSApellis Pharmaceuticals Inc6.95%-100.00%
PTGXProtagonist Therapeutics Inc6.71%-100.00%
NUVBNuvation Bio Inc - Class A6.48%-100.00%
FBIOPFortress Biotech Inc6.40%-100.00%
GMABGenmab5.92%-100.00%
SRPTSarepta Therapeutics Inc2.98%-100.00%
BMEABiomea Fusion Inc2.37%-100.00%
ACADAcadia Pharmaceuticals Inc1.36%-100.00%
FENCFennec Pharmaceuticals Inc1.33%-100.00%
FOLDAmicus Therapeutics Inc0.91%-100.00%
HOTHHoth Therapeutics Inc0.17%-100.00%
BBLGBone Biologics Corp0.02%-100.00%